BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9764641)

  • 21. [Uterine leiomyomas--risk factors].
    Trojnar-Podleśny M; Reroń A
    Ginekol Pol; 2003 Dec; 74(12):1572-7. PubMed ID: 15029752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances.
    Levy G; Hill MJ; Beall S; Zarek SM; Segars JH; Catherino WH
    J Assist Reprod Genet; 2012 Aug; 29(8):703-12. PubMed ID: 22584729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiology and pathogenesis of uterine leiomyomas: a review.
    Flake GP; Andersen J; Dixon D
    Environ Health Perspect; 2003 Jun; 111(8):1037-54. PubMed ID: 12826476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications.
    Ciarmela P; Islam MS; Reis FM; Gray PC; Bloise E; Petraglia F; Vale W; Castellucci M
    Hum Reprod Update; 2011; 17(6):772-90. PubMed ID: 21788281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroids: pathophysiology and current medical treatment.
    Nowak RA
    Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):223-38. PubMed ID: 10755039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAMS 2018 Utian Translational Science Symposium, October 2018, San Diego, California New therapies for leiomyomas: when surgery may not be the best option.
    The North American Menopause Society (NAMS)
    Menopause; 2019 Sep; 26(9):947-957. PubMed ID: 31453955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Technique and methods in uterine leiomyoma embolization].
    Helmberger TK; Jakobs TF; Reiser MF
    Radiologe; 2003 Aug; 43(8):634-40. PubMed ID: 14504763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
    Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving Toward Individualized Medicine for Uterine Leiomyomas.
    Laughlin-Tommaso SK; Stewart EA
    Obstet Gynecol; 2018 Oct; 132(4):961-971. PubMed ID: 30130343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium.
    Lessl M; Klotzbuecher M; Schoen S; Reles A; Stöckemann K; Fuhrmann U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2596-600. PubMed ID: 9253340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Uterine leiomyoma: pathogenesis and treatment].
    Fujii S
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Aug; 44(8):994-9. PubMed ID: 1402231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign leiomyoma with multiple metastases to vertebrae and calvarium: An index case with comprehensive review of endocrine targets.
    Elmaci İ; Altinoz MA; Ozlu BEK; Sari R; Er O; Danyeli AE; Karaarslan E
    Neurosurg Rev; 2021 Feb; 44(1):289-300. PubMed ID: 32078084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
    Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
    Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.
    Catherino WH; Eltoukhi HM; Al-Hendy A
    Semin Reprod Med; 2013 Sep; 31(5):370-9. PubMed ID: 23934698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations.
    Newbold RR; DiAugustine RP; Risinger JI; Everitt JI; Walmer DK; Parrott EC; Dixon D
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():769-73. PubMed ID: 11035980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
    Hassan MH; Salama SA; Arafa HM; Hamada FM; Al-Hendy A
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3949-57. PubMed ID: 17635941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
    Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
    Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogen-associated genes in uterine leiomyoma.
    Li S; McLachlan JA
    Ann N Y Acad Sci; 2001 Dec; 948():112-20. PubMed ID: 11795389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etiology, symptomatology, and diagnosis of uterine myomas.
    Parker WH
    Fertil Steril; 2007 Apr; 87(4):725-36. PubMed ID: 17430732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.